Unaudited Financial Results of the Company for half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 20.6 pts less than Nifty Microcap 250 and 19.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Deepak Chemtex reported a weaker first half of FY26. Standalone revenue from operations fell to ₹2,698.78 lakhs from ₹3,270.76 lakhs in H1 FY25, a drop of about 17.5%. Profit before tax slipped to ₹441.31 lakhs from ₹691.12 lakhs, and net profit declined to ₹342.99 lakhs (₹525.01 lakhs earlier), pushing EPS down to ₹3.16 from ₹4.83. On a consolidated basis (including DCL Speciality Chemicals, South West Chemicals, and Atlas Tints), revenue came in at ₹3,092.68 lakhs versus ₹3,885.99 lakhs, with PAT at ₹432.97 lakhs vs ₹563.56 lakhs. Operating cash flow swung to a positive ₹292.55 lakhs from negative ₹71.34 lakhs, and the auditor Mittal & Associates issued an unqualified limited review report. The company also confirmed that IPO proceeds of ₹2,304 lakhs have been fully utilised as per the stated objects.
Shareholders should note a clear slowdown in both top line and bottom line compared with the year-ago period, with margins under pressure. The positive flip in operating cash flow and full deployment of IPO funds for plant and working capital are encouraging signs, but near-term earnings momentum looks soft.